ARCHIVES

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

Sharfstein To Leave FDA

January 7, 2011

NCI’s Douglas Lowy and John Schiller Honored with National Medal

December 12, 2014

Funding Opportunities.

April 5, 2002

Centers Got $35 Million In NIH Construction $$; Send In Applications, Branch Chief Says

July 24, 1992

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999